Autoimmune Basis for Postural Tachycardia Syndrome



Status:Recruiting
Conditions:Peripheral Vascular Disease, Cardiology, Cardiology, Neurology, Neurology
Therapuetic Areas:Cardiology / Vascular Diseases, Neurology
Healthy:No
Age Range:18 - 50
Updated:2/1/2019
Start Date:February 2016
End Date:July 2021
Contact:Emily C Smith, RN
Email:autonomics@vumc.org
Phone:615.343.8649

Use our guide to learn which trials are right for you!

The purpose of this study is to see if some people with postural tachycardia syndrome (POTS)
have higher levels of immune proteins (autoantibodies) directed against receptors of the
autonomic nervous system, and if these autoantibodies make a difference in their POTS
symptoms. The investigators also want to see if the levels of these autoantibodies stay the
same over time.

Postural tachycardia syndrome (POTS) is a debilitating disorder resulting from cardiovascular
autonomic dysfunction, has many causes and is very difficult to treat effectively. The
investigators have identified the presence of autoantibodies (immune proteins) directed
against some receptors of the autonomic nervous system that can cause patient's symptoms on
standing.

The present study is designed to test the hypothesis that patients with POTS harbor
functional autoantibodies to adrenergic receptors that lead to an excessive tachycardia
characteristic of POTS. For this purpose, this study will define the prevalence, burden, and
the in vivo physiological significance of these adrenergic antibodies in a well-phenotyped
and representative cohort of patients with POTS and a matched cohort of healthy control
subjects, and will characterize the stability of these autoantibodies over time in affected
POTS patients.

Inclusion Criteria:

- 18-50 years old

- Postural Tachycardia Syndrome: Heart rate increase >30 bpm from supine within 10 min
of standing, in the absence of orthostatic hypotension (>20/10 mmHg fall in blood
pressure), with chronic symptoms (> 6 months), and in the absence of other acute cause
of orthostatic tachycardia.

- Able and willing to provide informed consent

- Female premenopausal subjects must utilize adequate birth control and willingness to
undergo serum beta-hCG testing

- The subject must understand and be able to comply with the study procedures and
restrictions.

Exclusion Criteria:

- Hypertension (>150 mmHg systolic and >100 mmHg diastolic) based on history or findings
at screening.

- Orthostatic hypotension (consistent drop in blood pressure >20/10 mmHg with 10 min
stand)

- Pregnancy

- Cardiovascular disease, such as myocardial infarction within 6 months, angina
pectoris, significant arrhythmia (sinus tachycardia is not excluded), deep vein
thrombosis, pulmonary embolism

- History of serious neurologic disease

- History or presence of significant immunological or hematological disorders

- Clinically significant gastrointestinal impairment that could interfere with dietary
compliance or drug absorption

- Impaired hepatic function (aspartate amino transaminase and/or alanine amino
transaminase >1.5 x upper limit of normal range)

- Impaired renal function (serum creatinine >1.5 mg/dL)

- Hematocrit <28%

- Current or concurrent disease that could affect the absorption, action or disposition
of the drug, or clinical or laboratory assessments.

- Any underlying or acute disease requiring regular medication that could possibly pose
a threat to the subject or make implementation of the protocol or interpretation of
the study results difficult

- Inability to comply with the protocol

Healthy control subjects will be healthy, non-smoking and on no chronic medications at the
time of the study. Healthy control subjects will be group-matched to the POTS patients for
age and gender. We will attempt to study female patients in the first half of their
menstrual cycle to minimize cyclical variability.
We found this trial at
2
sites
Nashville, Tennessee 37232
Phone: 615-875-1516
?
mi
from
Nashville, TN
Click here to add this to my saved trials
940 NE 13th St
Oklahoma City, Oklahoma 73190
(405) 271-6458
University of Oklahoma Health Sciences Center The OU Health Sciences Center is composed of seven...
?
mi
from
Oklahoma City, OK
Click here to add this to my saved trials